• Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright

    来源: Buzz FX / 10 1月 2025 08:04:14   America/Chicago


    Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from Analysts at HC Wainwright Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Research analysts at HC Wainwright started coverage on shares of Bright Minds Bios
    Read more...
分享